Modelling Neglected Tropical Diseases diagnostics: The sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Bottomley, Christian ^a   Isham, Valerie ^b   Vivas Martínez, Sarai ^c   Kuesel, Annette C ^d   Attah, Simon K ^f   Opoku, Nicholas O ^e   Lustigman, Sara ^g   Walker, Martin ^h   Basáñez, Maria Gloria ^h  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e University of Health and Allied Sciences Research Centre   (Ghana)

^f UNIVERSITY OF GHANA   (Ghana)

^g NEW YORK BLOOD CENTER   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnostics; Elimination; Ivermectin; Onchocerciasis; Prevalence; Sensitivity; Skin snips; Surveillance

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CHILD; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; FOLLOW UP; GHANA; GUATEMALA; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; ONCHOCERCIASIS; PARASITE PREVALENCE; SENSITIVITY AND SPECIFICITY; SKIN SNIP METHOD; VENEZUELA; ANIMAL; FEMALE; HEALTH SURVEY; ISOLATION AND PURIFICATION; NEGLECTED DISEASES; ONCHOCERCA VOLVULUS; PARASITOLOGY; SKIN;

IVERMECTIN;

ANIMALS; CAMEROON; FEMALE; GHANA; GUATEMALA; HUMANS; IVERMECTIN; NEGLECTED DISEASES; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; POPULATION SURVEILLANCE; SENSITIVITY AND SPECIFICITY; SKIN; VENEZUELA;

EID: 84974624180     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1605-3     Document Type: Article

References (76)

1. World Health Organization. 2012 progress report of WHO/APOC. Geneva: World Health Organization; 2012. Available: http://www.who.int/entity/apoc/publications/2012-progressreport. Accessed: 22 November 2015.
2. World Health Organization. 2013 progress report of WHO/APOC. Geneva: World Health Organization; 2013. Available: http://www.who.int/apoc/publications/2013-progressreport. Accessed: 22 November 2015.
3. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJD, van Oortmarssen G, Boatin BA, Habbema JDF. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ. 2002;80:384-90.
4. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3(7), e497.
5. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9), e1825.
6. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors. 2012;5:28.
7. World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: World Health Organization; 2012. Available: http://www.who.int/neglected-diseases/NTD-RoadMap-2012-Fullversion.pdf. Accessed: 9 November 2015.
8. World Health Organization. Eighteenth Session of the Joint Action Forum JAF18, Bujumbura; 2012. Available: http://www.who.int/entity/apoc/about/structure/jaf/Final-Communique-JAF-18-English-final-with-annexes.pdf. Accessed: 22 November 2015.
9. World Health Organization/Afican Programme for Onchocerciasis Control. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment; 2010. Available: http://www.who.int/apoc/oncho-elimination-report-english.pdf. Accessed: 9 November 2015.
10. World Health Organization. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis. Criteria and procedures. 2016. Available: http://apps.who.int/iris/bitstream/10665/204180/1/9789241510011-eng.pdf. Accessed: 25 January 2016.
11. Prost A, Prod'hon J. Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl). Med Trop (Mars). 1978;38(5):519-32. Article in French.
12. Moreau JP, Prost A, Prod'hon J. An attempt to normalize the methodology of clinico parasitologic surveys of onchocerciasis in West-Africa (author's transl). Med Trop (Mars). 1978;38(1):43-51. Article in French.
13. African Programme for Onchocerciasis Control (APOC). Report of the 39th session of the technical consultative committee (TCC), September 2014. Ouagadougou: World Health Organization/African Programme for Onchocerciasis Control; 2015. Available: http://www.who.int/apoc/about/structure/tcc/en/. Accessed: 26 January 2016.
14. World Health Organization/African Programme for Onchocerciasis Control. Report of the consultative meetings on strategic options and alternative treatment strategies for accelerating onchocerciasis elimination in Africa. 2015. WHO/MG/15.20. Available: http://www.who.int/apoc/ATS-Report-2015.12.pdf?ua=1. Accessed: 25 January 2016.
15. Toè L, Adjami AG, Boatin BA, Back C, Alley ES, Dembele N, et al. Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in West Africa. Trans R Soc Trop Med Hyg. 2000;94(5):519-25.
16. Ozoh G, Boussinesq M, Bissek AC, Kobangue L, Kombila M, Mbina JR, et al. Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Health. 2007;12(1):123-9.
17. World Health Organization/OCP. Epidemiological surveillance: diethyl-carbamazine patch method, field work and training manual. Geneva: World Health Organization; 2002. Available: http://www.who.int/apoc/publications/guidefortraindec-patch. Accessed: 26 November 2015.
18. Awadzi K, Opoku NO, Attah SK, Lazdins-Helds JK, Kuesel AC. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch. Parasit Vectors. 2015;8(1):515.
19. Vlaminck J, Fischer PU, Weil GJ. Diagnostic tools for onchocerciasis elimination programs. Trends Parasitol. 2015; doi: 10.1016/j.pt.2015.06.007. [Epub ahead of print].
20. Boatin BA, Toé L, Alley ES, Nagelkerke NJD, Borsboom G, Habbema JDF. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology. 2002;125(6):545-52.
21. Taylor HR, Muñoz B, Keyvan-Larijani E, Greene BM. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med Hyg. 1989;41(4):467-71.
22. McCarthy JS, Lustigman S, Yang G-J, Barakat RM, García HH, Sripa B, et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis. 2012;6(4), e1601.
23. Collins RC, Brandling-Bennett AD, Hollman RB, Campbell CC, Darsie RF. Parasitological diagnosis of onchocerciasis: comparison of incubation media and incubation times for skin snips. Am J Trop Med Hyg. 1980;29(1):35-41.
24. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, Richards Jr FO, et al. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg. 1992;47(2):156-69.
25. Basáñez MG, Yarzábal L, Takaoka H, Suzuki H, Noda S, Tada I. The vectoral role of several blackfly species (Diptera: Simuliidae) in relation to human onchocerciasis in the Sierra Parima and Upper Orinoco regions of Venezuela. Ann Trop Med Parasitol. 1988;82(6):597-611.
26. Kale OO, Bammeke AO, Ayeni O. An evaluation of skin snip techniques used in the quantitative assessment of microfilarial densities of Onchocerca volvulus. Bull World Health Organ. 1974;51(5):547-9.
27. Awadzi K, Roulet H, Bell DR. The chemotherapy of onchocerciasis V. A standard method for the determination of microfilarial density in skin snips. Ann Trop Med Parasitol. 1980;74(3):363-6.
28. Schulz-Key H, Karam M. Periodic reproduction of Onchocerca volvulus. Parasitology Today. 1986;2(10):284-6.
29. Taylor HR, Keyvan-Larijani E, Newland HS, White AT, Greene BM. Sensitivity of skin snips in the diagnosis of onchocerciasis. Trop Med Parasitol. 1987;38(2):145-7.
30. Vivas-Martínez S, Basáñez MG, Botto C, Villegas L, García M, Curtis CF. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela. Parasitology. 2000;121(5):527-34.
31. Vivas-Martínez S, Basáñez MG, Grillet ME, Weiss H, Botto C, García M, et al. Onchocerciasis in the Amazonian focus of southern Venezuela: altitude and blackfly species composition as predictors of endemicity to select communities for ivermectin control programmes. Trans R Soc Trop Med Hyg. 1998;92(6):613-20.
32. Vivas-Martínez S, Basáñez MG, Botto C, Rojas S, García M, Pacheco M, et al. Amazonian onchocerciasis: parasitological profiles by host-age, sex, and endemicity in southern Venezuela. Parasitology. 2000;121(5):513-25.
33. Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis. 2014;8(6), e2953.
34. MacDonald AJ, Turaga PS, Harmon-Brown C, Tierney TJ, Bennett KE, McCarthy MC, et al. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect Immun. 2002;70(6):2796-804.
35. Cupp EW, Ochoa JO, Collins RC, Cupp MS, Gonzales-Peralta C, Castro J, et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg. 1992;47(2):170-80.
36. Brandling-Bennett AD, Anderson J, Fuglsang H, Collins R. Onchocerciasis in Guatemala. Epidemiology in fincas with various intensities of infection. Am J Trop Med Hyg. 1981;30(5):970-81.
37. Basáñez MG, Yarzábal L. Onchocerciasis in the Sierra Parima and Upper Orinoco regions, Federal Territory of Amazonas, Venezuela. In: Miller MJ, Love EJ, editors. Parasitic Diseases: Treatment and Control. Florida: CRC Press; 1989. p. 231-56.
38. Duke BOL. The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol. 1993;44(2):61-8.
39. Basáñez MG, Boussinesq M. Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci. 1999;354(1384):809-26.
40. Basáñez MG, Pion SDS, Boakes E, Filipe JAN, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(5):310-22.
41. Turner HC, Churcher TS, Walker M, Osei-Atweneboana MY, Prichard RK, Basáñez MG. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis. 2013;7(4), e2169.
42. Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, et al. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS One. 2014;9(12), e115886.
43. Bottomley C, Isham V, Collins RC, Basáñez MG. Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology. 2008;135(13):1571-81.
44. Tallis GM, Leyton M. Stochastic models of populations of helminthic parasites in the definitive host. I. Math Biosci. 1969;4(1-2):39-48.
45. Kershaw WE, Duke BOL, Budden FH. Distribution of microfilariae of O. volvulus in the skin; its relation to the skin changes and to eye lesions and blindness. Br Med J. 1954;2(4890):724-9.
46. Duerr HP, Dietz K, Büttner DW, Schulz-Key H. A stochastic model for the aggregation of Onchocerca volvulus in nodules. Parasitology. 2001;123(2):193-201.
47. R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015.
48. Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M. The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol. 2004;34(4):463-73.
49. Plaisier AP, Alley ES, Boatin BA, Van Oortmarssen GJ, Remme H, De Vlas SJ, et al. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis. 1995;172(1):204-10.
50. Kläger S, Whitworth JAG, Post RJ, Chavasse DC, Downham MD. How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol. 1993;44(4):305-10.
51. Kläger SL, Whitworth JAG, Downham MD. Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Trop Med Int Health. 1996;1(5):581-9.
52. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, Duke BOL. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet. 2002;360(9328):203-10.
53. Pion SDS, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, Njiokou F, et al. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon. PLoS Negl Trop Dis. 2013;7(2), e2084.
54. Turner HC, Walker M, Churcher TS, Basáñez MG. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African savannah: EpiOncho projections. Parasit Vectors. 2014;7:241.
55. Stolk WA, Walker M, Coffeng LE, Basáñez MG, de Vlas SJ. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors. 2015;8(1):552.
56. Plaisier AP, van Oortmarssen GJ, Remme J, Habbema JD. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop. 1991;48(4):271-84.
57. Vuong PN, Bain O, Cabaret J, Petit G, Prod'hon J, Ranque P, et al. Forest and savanna onchocerciasis: comparative morphometric histopathology of skin lesions. Trop Med Parasitol. 1988;39(2):105-10.
58. Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, et al. Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis. 2014;59(7):923-32.
59. World Health Organization/African Programme for Onchocerciasis Control. Guidelines for revising ivermectin treatment boundaries within the context of onchocerciasis elimination. 2015. WHO/MG/15.21. Available: http://www.who.int/apoc/ATS-Report-Annex1-APOC-Guidelines-for-revising-IVM-Tx-boundaries.pdf. Accessed 25 January 2016.
60. Renz A, Wenk P. The distribution of the microfilariae of Onchocerca volvulus in the different body regions in relation to the attacking behaviour of Simulium damnosum s.l. in the Sudan savanna of northern Cameroon. Trans R Soc Trop Med Hyg. 1983;77(6):748-52.
61. Basáñez MG, Churcher TS, Grillet ME. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol. 2009;68:263-313.
62. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg. 1998;58(4):461-9.
63. Boussinesq M, Gardon J, Kamgno J, Pion SDS, Gardon-Wendel N, Chippaux JP. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Ann Trop Med Parasitol. 2001;95(5):495-507.
64. Mectizan® Expert Committee/Technical Consultative Committee. Recommendations for the treatment of onchocerciasis with Mectizan® in areas co-endemic for onchocerciasis and loiasis. 2004. Available: http://www.who.int/apoc/ATS-Report-Annex3-MEC-TCC-Guidelines-for-IVM-TxinLoaendemicareas.pdf?ua=1. Accessed: 25 January 2016.
65. D'Ambrosio MV, Bakalar M, Bennuru S, Reber C, Skandarajah A, Nilsson L, et al. Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope. Sci Transl Med. 2015;7(286):286re4.
66. Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PW, Tendongfor N, Adzemye BF, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit Vectors. 2015;8:202.
67. Taylor MJ, Hoerauf A, Townson S, Slatko BE, Ward SA. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology. 2014;141(1):119-27.
68. Debrah AY, Specht S, Klarmann-Schulz U, Batsa L, Mand S, Marfo-Debrekyei Y, et al. Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: a randomized, placebo-controlled, double-blind trial. Clin Infect Dis. 2015;61(4):517-26.
69. Walker M, Specht S, Churcher TS, Hoerauf A, Taylor MJ, Basáñez MG. Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness. Clin Infect Dis. 2015;60(8):1199-207.
70. Kilian HD. The use of a topical Mazzotti test in the diagnosis of onchocerciasis. Trop Med Parasitol. 1988;39(3):235-8.
71. Newland HS, Kaiser A, Taylor HR. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. Trop Med Parasitol. 1987;38(2):143-4.
72. Stingl P, Ross M, Gibson DW, Ribas J, Connor DH. A diagnostic patch test for onchocerciasis using topical diethylcarbamazine. Trans R Soc Trop Med Hyg. 1984;78(2):254-8.
73. Bradley JE, Unnasch TR. Molecular approaches to the diagnosis of onchocerciasis. Adv Parasitol. 1996;37:57-106.
74. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science. 1991;251(5001):1603-5.
75. Oguttu D, Byamukama E, Katholi CR, Habomugisha P, Nahabwe C, Ngabirano M, et al. Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience. Am J Trop Med Hyg. 2014;90(2):339-45.
76. Vincent JA, Lustigman S, Zhang S, Weil GJ. A comparison of newer tests for the diagnosis of onchocerciasis. Ann Trop Med Parasitol. 2000;94(3):253-8.